Endonovo Therapeutics, Inc. (ENDV)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Endonovo Therapeutics Shareholders Equity (Quarterly) : -30.05M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.05M |
| March 31, 2026 | -29.46M |
| December 31, 2025 | -28.87M |
| September 30, 2025 | -28.33M |
| June 30, 2025 | -27.82M |
| March 31, 2025 | -27.26M |
| December 31, 2024 | -26.80M |
| September 30, 2024 | -26.18M |
| June 30, 2024 | -25.48M |
| March 31, 2024 | -24.80M |
| December 31, 2023 | -24.11M |
| September 30, 2023 | -22.96M |
| June 30, 2023 | -22.20M |
| March 31, 2023 | -24.37M |
| December 31, 2022 | -32.18M |
| September 30, 2022 | -19.60M |
| June 30, 2022 | -19.16M |
| March 31, 2022 | -18.04M |
| December 31, 2021 | -15.77M |
| September 30, 2021 | -18.22M |
| June 30, 2021 | -16.98M |
| March 31, 2021 | -15.97M |
| December 31, 2020 | -14.37M |
| September 30, 2020 | -12.76M |
| June 30, 2020 | -12.18M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.14M |
| December 31, 2019 | -20.50M |
| September 30, 2019 | -16.56M |
| June 30, 2019 | -16.25M |
| March 31, 2019 | -11.62M |
| December 31, 2018 | -11.39M |
| September 30, 2018 | -14.08M |
| June 30, 2018 | -9.115M |
| March 31, 2018 | -8.621M |
| December 31, 2017 | -9.549M |
| September 30, 2017 | -13.17M |
| June 30, 2017 | -9.140M |
| March 31, 2017 | -13.06M |
| December 31, 2016 | -8.560M |
| September 30, 2016 | -8.517M |
| June 30, 2016 | -7.249M |
| March 31, 2016 | -9.012M |
| December 31, 2015 | -9.274M |
| September 30, 2015 | -5.928M |
| June 30, 2015 | -5.396M |
| March 31, 2015 | -4.841M |
| December 31, 2014 | -4.691M |
| September 30, 2014 | -4.483M |
| June 30, 2014 | -4.955M |
| March 31, 2014 | -4.754M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Accuray, Inc. | 41.70M |
| Perspective Therapeutics, Inc. | 323.86M |
| Orthofix Medical, Inc. | 429.18M |
| ResMed, Inc. | 6.585B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0448M |
| Total Liabilities (Quarterly) | 30.09M |
| Debt to Equity Ratio | -0.2343 |
| Current Ratio | 0.0014 |
| Net Debt Paydown Yield | -1.87K% |